Neuraxpharm, Pharmathen

Neuraxpharm and Pharmathen enter into strategic co-development agreement to develop long-acting injectable therapies

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

Neuraxpharm United States of America Germany United Kingdom Spain

View original content:https://www.prnewswire.co.uk/news-releases/neuraxpharm-and-pharmathen-enter-into-strategic-co-development-agreement-to-develop-long-acting-injectable-therapies-302329350.html

en | boerse | 67930817 |